Clinical trial
A Comparative Effectiveness Trial of Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail
NCT04408313 is registered in ClinicalTrials.gov with Friends Research Institute, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparative Effectiveness Trial of Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail
- Lead sponsor
- Friends Research Institute, Inc.
- Phase
- Phase 2/3
- Overall status
- Active, not recruiting
- Start date
- October 28, 2020
- Completion date
- May 31, 2026
- Enrollment
- 240 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
opioid-use disorder